Otsuka Holdings Co Ltd (OTSKY)
20.63
+0.18
(+0.86%)
USD |
OTCM |
May 03, 16:00
Otsuka Holdings Free Cash Flow (Quarterly): -25.21M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -25.21M |
December 31, 2023 | 392.29M |
September 30, 2023 | 317.71M |
June 30, 2023 | 113.55M |
March 31, 2023 | 377.84M |
December 31, 2022 | 178.56M |
September 30, 2022 | 239.25M |
June 30, 2022 | 13.24M |
March 31, 2022 | 366.97M |
December 31, 2021 | -287.51M |
September 30, 2021 | 494.69M |
June 30, 2021 | 311.98M |
March 31, 2021 | 535.45M |
December 31, 2020 | 214.48M |
September 30, 2020 | 447.58M |
June 30, 2020 | 214.65M |
March 31, 2020 | 387.75M |
December 31, 2019 | -89.62M |
September 30, 2019 | 707.03M |
June 30, 2019 | 297.11M |
March 31, 2019 | 270.91M |
December 31, 2018 | 122.97M |
September 30, 2018 | 329.46M |
June 30, 2018 | -27.66M |
March 31, 2018 | 138.50M |
Date | Value |
---|---|
December 31, 2017 | 49.34M |
September 30, 2017 | 79.39M |
June 30, 2017 | 1.595M |
March 31, 2017 | 95.06M |
December 31, 2016 | -303.85M |
September 30, 2016 | 357.08M |
June 30, 2016 | 305.51M |
March 31, 2016 | 290.53M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-287.51M
Minimum
Dec 2021
707.03M
Maximum
Sep 2019
260.39M
Average
304.54M
Median
Free Cash Flow (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 476.74M |
Nxera Pharma Co Ltd | -9.318M |
PeptiDream Inc | 21.30M |
Stemcell Holdings Inc | -- |
Healios KK | -8.073M |